p53 activates circASCC3 to repress R-loops and enhance resistance to chemotherapy.

Proc Natl Acad Sci U S A

Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.

Published: March 2025

The tumor suppressor p53 can trigger tumor resistance to chemotherapy by facilitating DNA damage repair and maintaining genomic integrity. Here, we report that a p53-induced circular RNA circASCC3 promotes chemotherapeutic resistance by resolving R-loops. Our results reveal that p53 directly activates the transcription of , the host gene of circASCC3. In addition, the RNA-binding protein SFPQ is identified to inhibit the formation of circASCC3 by associating with its flanking regions. Importantly, p53 facilitates the formation of circASCC3 by repressing the expression of SFPQ. CircASCC3 has a marginal effect on the survival and growth of cancer cells under normal growing conditions but surprisingly boosts their survival and growth in response to DNA damage stress. Mechanistic analysis reveals that circASCC3 binds to the DEAD-box RNA helicase DDX5 to inhibit its proteasomal degradation. This results in the prevention of R-loop accumulation due to DNA damage, thereby conferring tumor resistance to chemotherapy. Together, our study uncovers that p53 activates circASCC3 to promote R-loop resolution, which maintains genomic stability and potentially contributes to chemoresistance.

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.2415869122DOI Listing

Publication Analysis

Top Keywords

resistance chemotherapy
12
dna damage
12
p53 activates
8
circascc3
8
activates circascc3
8
tumor resistance
8
formation circascc3
8
survival growth
8
p53
5
circascc3 repress
4

Similar Publications

Pituitary neuroendocrine tumors (PitNETS) are common intracranial tumors, but extrasellar or ectopic PitNETS are very rare and supposed to originate from some pituitary remnants. They are mostly found in sphenoidal sinus. But particularly, ectopic clival PitNETS are highly aggressive and can cause bone invasion and can be misdiagnosed as other lesions of the skull base such as chordomas.

View Article and Find Full Text PDF

Combatting antibiotic resistance in Gardnerella vaginalis: A comparative in silico investigation for drug target identification.

PLoS One

March 2025

Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.

Gardnerella vaginalis is the most frequently identified bacterium in approximately 95% of bacterial vaginosis (BV) cases. This species often exhibits resistance to multiple antibiotics, posing challenges for treatment. Therefore, there is an urgent need to develop and explore alternative therapeutic strategies for managing bacterial vaginosis.

View Article and Find Full Text PDF

Microfluidic isolation and release of live disseminated breast tumor cells in bone marrow.

PLoS One

March 2025

Department of Mechanical and Aerospace Engineering, Interdisciplinary Microsystems Group, Gainesville, Florida, United States of America.

Breast cancer represents a significant therapeutic challenge due to its aggressive nature and resistance to treatment. A major cause of treatment failure in breast cancer is the presence of rare, low-proliferative disseminated tumor cells (DTCs) in distant organs including the bone marrow. This study introduced a microfluidic-based approach to improve the immunodetection and isolation of these rare DTCs for downstream analysis, with an emphasis on optimizing immunocapture, release, and enrichment methods of live DTCs as compared to the standard approach for blood-borne circulating tumor cells (CTCs).

View Article and Find Full Text PDF

Assessment of the endectocide efficacy of a pour-on topical solution containing fluazuron, fipronil and eprinomectin in cattle.

Vet Res Commun

March 2025

Faculdade de Ciências Agrarias e Veterinária (FCAV), Universidade Estadual de São Paulo (Unesp), Jaboticabal, São Paulo, Brasil.

The present study aimed to evaluate the effectiveness of a new formulation composed of the chemical active ingredients benzoylphenylurea, phenylpyrazole and macrocyclic lactone, which have different mechanisms of action on the most important parasites, such as R. microplus, H. irritans, D.

View Article and Find Full Text PDF

Recent insights on phage therapy against multidrug-resistant Acinetobacter baumannii.

AMB Express

March 2025

Department of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Cairo, 11566, Egypt.

Acinetobacter baumannii is a prevalent clinical pathogen commonly found to be multidrug-resistant (MDR), causing serious to life-threatening infections, particularly hospital-acquired infections with limited therapeutic options. The MDR phenotype developed against this critical pathogen is increasingly developed globally, reaching a pan-drug-resistant phenotype conferring non-susceptibility to all antimicrobials used in its treatment according to the standard guidelines. Therefore, it is critical to develop innovative treatment approaches, such as phage therapy, considering the rise in drug-resistant A.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!